Robert Bies

  • 2720 Citations
  • 28 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Robert Bies is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants

Indiana University Center for Pediatric Pharmacology

Flockhart, D. A., Renbarger, J., Bies, R., Renbarger, J., Robertson, K., Bies, R. R., Haneline, L., Flockhart, D. A., Haneline, L., Robertson, K. & Bies, R.

National Institutes of Health


Project: Research project

  • Publications

    A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma

    Fountzilas, C., Gupta, M., Lee, S., Krishnamurthi, S., Estfan, B., Wang, K., Attwood, K., Wilton, J., Bies, R., Bshara, W. & Iyer, R., Mar 31 2020, In : British Journal of Cancer. 122, 7, p. 963-970 8 p.

    Research output: Contribution to journalArticle

  • Modeling HIV pre-exposure prophylaxis

    Straubinger, T., Kay, K. & Bies, R., Jan 1 2020, In : Frontiers in Pharmacology. 10, 1514.

    Research output: Contribution to journalReview article

    Open Access
  • Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients

    Karas, S., Etheridge, A. S., Tsakalozou, E., Ramírez, J., Cecchin, E., van Schaik, R. H. N., Toffoli, G., Ratain, M. J., Mathijssen, R. H. J., Forrest, A., Bies, R. R. & Innocenti, F., May 1 2020, In : AAPS Journal. 22, 3, 59.

    Research output: Contribution to journalArticle

  • Circadian patterns of hallucinatory experiences in patients with schizophrenia: Potentials for chrono-pharmacology

    Koizumi, T., Suzuki, T., Pillai, N. S., Bies, R. R., Takeuchi, H., Yoshimura, K., Mimura, M. & Uchida, H., Oct 2019, In : Journal of Psychiatric Research. 117, p. 1-6 6 p.

    Research output: Contribution to journalArticle

  • Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI: 10.1002/pst.1873

    ASA Special Interest Group on Statistics and Pharmacometrics/ASA Special Interest Group on Statistics and Pharmacometrics (SIG SxP), May 1 2019, In : Pharmaceutical Statistics. 18, 3, p. 278-281 4 p.

    Research output: Contribution to journalLetter